Clinical Trial Update: Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM [Phase 2]

View source ↗

Summary

Phase II clinical trial investigating regorafenib plus toripalimab with radiofrequency ablation in colorectal cancer liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Cancer Liver Metastases

Drugs mentioned

• Regorafenib (regorafenib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer Liver Metastases | Phase 2 | Status: UNKNOWN